Tamoxifen, a Selective Estrogen Receptor Modulator, Reduces Ischemic Damage Caused by Middle Cerebral Artery Occlusion in the Ovariectomized Female Rat
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Previous work has demonstrated that physiological concentrations of 17β-estradiol can protect the female rat brain against middle cerebral artery occlusion (MCAO)-induced ischemic damage. The present study examined whether therapeutic doses of the clinically relevant selective estrogen receptor modulator (SERM), tamoxifen, can similarly protect the female rat brain against ischemic stroke damage. Adult female rats were bilaterally ovariectomized and implanted subcutaneously with either a placebo or tamoxifen time-release pellet (0.1, 0.8 or 2.4 mg/kg/day). One week later, the animals underwent permanent MCAO to assess the protective ability of the different tamoxifen doses on brain infarct size. As expected, MCAO produced a large infarct (∼53%) of the affected cerebral hemisphere in placebo (control) animals. The 0.1 mg/kg/day dose of tamoxifen did not exhibit any significant protective effects, however; the 0.8 and 2.4 mg/kg/day doses of tamoxifen, which are in the therapeutic range, dramatically reduced infarct of the affected cerebral hemisphere (∼70% reduction) as compared to the controls. The reduction of infarct size was primarily due to protection of two major structures, the cerebral cortex and striatum. Laser Doppler analysis further revealed that tamoxifen had no significant effect on cerebral blood flow either before or after MCAO, suggesting that tamoxifen protection is independent of cerebral blood flow changes. Further studies showed that tamoxifen pellets implanted at the time of MCAO did not reduce infarct size, suggesting that pretreatment with tamoxifen is necessary to observe a protective effect. These studies suggest that clinically important SERMs may have an additional unrecognized beneficial effect of protection of the female brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0398com · Cited by 115 · cited 1×
“Our finding that tamoxifen has estrogen-like neuroprotective effects in the brain adds to a growing literature demonstrating estrogen-like effects of tamoxifen in the regulation of glucose transporters and IGF-1 expression in the primate cerebral cortex [”
BackgroundAcute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion
Kimelberg, H. K., Feustel, P. J., Jin, Y., Paquette, J., Boulos, A., Keller, R. W., & Tranmer, B. I. (2000) · NeuroReport · doi:10.1097/00001756-200008210-00014 · Cited by 108 · cited 1×
“Although there is generally little indication to prescribe tamoxifen to males, it is interesting to note that it may be protective in males as well, as Kimelberg et al. [”
Background
Cited by
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 647
Self-citationAstrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke
Liu, Z., & Chopp, M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.008 · Cited by 590
Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy
Kimelberg, H. K. (2005) · Glia · doi:10.1002/glia.20174 · Cited by 257
Tian, D., Liu, J., Xie, M., Zhan, Y., Qu, W., Yu, Z., Tang, Z., Pan, D., & Wang, W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06077.x · Cited by 98
Metadata
- Authors
- Mehta, S. H., Dhandapani, K. M., De Sevilla, L. M., Webb, R. C., Mahesh, V. B., & Brann, D. W.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 77
- Issue
- 1
- Pages
- 44-50
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2016377682
- Cited by
- 78
- References
- 2
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tamoxifen, a Selective Estrogen Receptor Modulator, Reduces Ischemic Damage Caused by Middle Cerebral Artery Occlusion in the Ovariectomized Female Rat. https://app.cochat.ai/papers/10.1159/000068332
- The paper
- Mehta, S. H., Dhandapani, K. M., De Sevilla, L. M., Webb, R. C., Mahesh, V. B., & Brann, D. W. (2003). Tamoxifen, a Selective Estrogen Receptor Modulator, Reduces Ischemic Damage Caused by Middle Cerebral Artery Occlusion in the Ovariectomized Female Rat. Neuroendocrinology. https://doi.org/10.1159/000068332
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.